Amicus Therapeutics Inc. (FOLD) Q3 2023 Earnings Call Transcript

35 mins read
57 views

Amicus Therapeutics Inc. (NASDAQ:FOLD) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET

Company Participants

Andrew Faughnan – Vice President, Investor Relations

Bradley Campbell – President, Chief Executive Officer

Sebastien Martel – Chief Business Officer

Simon Harford – Chief Financial Officer

Jeff Castelli – Chief Development Officer

Mitchell Goldman – Chief Medical Officer

Ellen Rosenberg – Chief Legal Officer

Mike Kaveney – President of U.S. Commercial Business and Head of Global Marketing

Conference Call Participants

Tazeen Ahmad – Bank of America

Anupam Rama – JPMorgan

Ritu Baral – TD Cowen

Joseph Schwartz – Leerink Partners

Sarah Kwok – UBS

Kristen Kluska – Cantor Fitzgerald

Dae Gon Ha – Stifel

Gil Blum – Needham & Company

Jeff Hung – Morgan Stanley

Operator

Good morning, ladies and gentlemen and welcome to the Amicus Therapeutics Third Quarter 2023 Financial Results Conference Call and webcast. [Operator Instructions] As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Mr. Andrew Faughnan, Vice President of Investor Relations. You may begin.

Andrew Faughnan

Good morning. Thank you for joining our conference call to discuss Amicus Therapeutics’ third quarter 2023 financial results and corporate highlights. Leading today’s call we have Bradley Campbell, President and Chief Executive Officer; Sebastien Martel, Chief Business Officer, Simon Harford, Chief Financial Officer, and Dr. Jeff Castelli, Chief Development Officer. Joining for Q&A is Dr. Mitchell Goldman, Chief Medical Officer, Ellen Rosenberg, Chief Legal Officer, and Mike Kaveney, President of U.S. Commercial Business and Head of Global Marketing.

As referenced on Slide 2, we may make forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 relating to our business, as well as our plans and prospects. Our forward-looking statements should not be regarded as representation by us that any of

Read the full article here

Leave a Reply

Your email address will not be published.

Previous Story

House Oversight Committee subpoenas Hunter and James Biden

Next Story

Cruise recalls all of its self driving cars to fix their programming

Latest from News